Screening and approval of new drug R & D projects and practical analysis of comprehensive information mining

The second training course on "screening and approval of new drug R & D projects and practical analysis of comprehensive information mining" was held It was informed to all relevant units that with the continuous introduction of policies for the pharmaceutical industry, the pharmaceutical R & D and industrial environment in China has also ushered in a new situation The core competitiveness of pharmaceutical enterprises is drug research and development, and the project approval work in drug research and development is a key issue that directly affects the success of new drug development Therefore, how to effectively avoid the risk of development, project approval demonstration is extremely important, and it is also the focus of every pharmaceutical enterprise before research and development Therefore, it is more and more important for the development of pharmaceutical enterprises to effectively use all kinds of medical data to search, analyze and find solutions! In order to further improve the level of research and development of new drugs and the retrieval and utilization of medical information in the current situation, how should our R & D personnel make full use of this huge Internet system to quickly transfer and exchange information from all over the world, so that our R & D personnel can speed up their exploration, More importantly, it improves the accuracy and utilization of literature retrieval, which effectively promotes the information retrieval and utilization of current big data, so as to improve the core competitiveness of pharmaceutical enterprises Our company is scheduled to hold the second special training course of "screening and approval of new drug R & D projects and practical analysis of comprehensive information mining" in Beijing on January 10-12, 2019 Now we will inform the following matters: supporting unit: Qingdao science and technology innovation compatibility research center (polymer material specialist workstation) supporting media: arrangement of drug intelligence network meeting Meeting time: January 10-12, 2019 (full day registration on January 10): Beijing (the specific place is directly sent to the applicants) meeting content November 11 (09:00-12:00; 14:00-17:00) speaker: Li Tianquan, senior engineer, long-term engaged in new drug research and development and new product development strategy, undertaken a number of national and provincial research and development projects, and obtained 5 national invention patents As the director of new drug research and development for many years, he has successfully developed dozens of new products, including three types of new drugs He is the co-founder of the pharmaceutical intelligence network, which has jointly established the professional China's leading pharmaceutical big data service platform - pharmaceutical intelligence network Specially invited lecturer of the association 1、 Project screening and project investigation 1 How to determine the key areas and directions of new drug R & D 2 How to effectively screen the objectives 3 How to analyze and mine the selected varieties (Research and development status analysis, market demand and competition pattern analysis, technology evaluation, risk consideration, etc.) 4 Case analysis and problem discussion 2 Application summary of medical information 1 The important role of data and information 2 The demand for data and information in all aspects of the pharmaceutical industry 3 The principle of data and information application 4 The development trend of the utilization of pharmaceutical database 5 Special topic of medical information mining and utilization 3 Introduction to the common pharmaceutical Internet database 1 The main way to obtain pharmaceutical information 2 Foreign pharmaceutical database 3 Domestic pharmaceutical database 4 Retrieval and demonstration 4、 Mining and utilization of consistency evaluation data and information 1 Consistency evaluation of generic drugs based on "number" theory 2 Market Research and project decision-making of consistency evaluation 3 How to find and determine reference preparations (in-depth interpretation of rld and RS) 4 How to find the dissolution method and data of reference preparations 5 Using information retrieval to crack the prescription process of original drugs 1 The relationship between the prescription process and efficacy of generic drugs 2 Nature of raw materials and acquisition methods 3 Acquisition and mining of formulation process information 4 Acquisition of more information of reference preparation 6 On site question discussion and answer on November 12 (09:00-12:00; 13:30-16:30) speaker: Deng Wanhe, successively worked in Novartis, Takeda pharmaceutical, PPD consulting and other companies, and has been engaged in drug registration for nearly 10 years He has obtained professional degrees in medicine and computer science, and is a senior expert in medical information retrieval and utilization Special lecturer of the association 1、 Information acquisition and mining of new drug R & D 1 Rapid acquisition and analysis of indications to be developed 2 Acquisition and utilization of competitive product R & D information 3 Taking a drug R & D as an example, how to quickly obtain relevant information needed for drug R & D and how to use 4 Retrieval and utilization of European, American, Japanese and Chinese review reports 2 Discussion and answer of on-site questions Speaker: Hou Yu, Professor of Hebei University of science and technology, President of Chongqing Kangzhou big data Development Institute, chief expert of pharmaceutical intelligence data He has been engaged in research and development in the field of medicine for a long time, and has made great achievements in information retrieval and information resource construction He has completed more than 20 scientific research projects, applied for 6 patents, and published more than 50 papers After 30 years, it has created a large number of medical databases and is a well-known expert in the construction / application of medical information in China Special lecturer of the association 1、 Acquisition and mining of drug research comprehensive information 1 Acquisition and mining of new drug information in research 2 Acquisition and mining of generic product information 3 Case analysis and problem discussion 2 Retrieval and mining of pharmaceutical industry patent comprehensive information 1 Construction and extension of pharmaceutical patent protection chain 2 Retrieval methods and skills of pharmaceutical patent literature 3 Acquisition and information mining of pharmaceutical patent specification 4 In depth analysis of the scope of drug patent protection 5 Case analysis and problem discussion Participants: new drug R & D personnel and registration and application personnel of pharmaceutical enterprises, pharmaceutical research institutes (institutes), medical schools (schools), quality director of manufacturing enterprises, cro personnel of new drug R & D Explanation of the meeting 1 Theoretical explanation, case analysis, special lecture, Interactive Q & A 2 The keynote speakers and guests are all senior experts in the industry Welcome to call for consultation 3 The training certificate will be issued by the Association for those who have completed all the training courses 4 The enterprise needs special internal training and guidance such as R & D and GMP Please contact the meeting affairs group for meeting expenses: 2500 yuan / person (meeting expenses include: training, discussion, information, etc.); the accommodation and food will be arranged uniformly, and the expenses will be borne by themselves , the accommodation shall be arranged in a unified way, and the expenses shall be borne by oneself Registration method 1 Scan the QR code below to register 2 Click http://f86dij8j8497bi88.mikecrm.com/mhwejry to register to attend the conference ~ 3 Tel: 18323856316